Does TCT report require cervical biopsy for HSIL?

The TCT report shows that HSIL generally requires cervical biopsy. HSIL is the abbreviation for high-grade squamous intraepithelial lesions, which belong to the more severe stage of cervical precancerous lesions and usually require cervical biopsy to further clarify pathological grading. Cervical biopsy is performed by sampling suspicious lesion tissue under the guidance of a colposcopy for pathological examination. This method can directly observe the vascular morphology and epithelial changes on the surface of the cervix, accurately identify the specific range of lesions, and make pathological grades for the severity of lesions. Vaginal biopsy under colposcopy has more diagnostic value than simple cytology examination, and can distinguish between minimally invasive cancer or occult lesions. Cervical biopsy is more necessary for women over 40 years old or patients with HSIL lasting for more than 1 year. Some special circumstances may delay biopsy, such as pregnant patients who can have a follow-up examination at 6 weeks postpartum. Patients with severe immune dysfunction need to assess the risk of infection, and acute cervicitis needs to be controlled first. Before biopsy, it is necessary to avoid the menstrual period and complete blood routine and coagulation function tests. Doctors will develop personalized diagnosis and treatment plans based on factors such as age, fertility needs, and the scope of the disease, which may require comprehensive judgment through HPV typing testing. After being diagnosed with high-grade squamous intraepithelial lesions, treatment options include cervical circular resection, cryotherapy, etc. Regular follow-up is essential. Maintaining good lifestyle habits, conducting cervical cancer screening on time, and avoiding multiple sexual partners can reduce the risk of disease progression. All examinations and treatments must be conducted under the guidance of a professional gynecologist.